Neoleukin Therapeutics, Inc. Profile Avatar - Palmy Investing

Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic …

Drug Manufacturers - Specialty & Generic
US, Seattle [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of NLTX's Analysis
CIK: - CUSIP: 64049K104 ISIN: US64049K2033 LEI: - UEI: -
Secondary Listings
NLTX has no secondary listings inside our databases.